SCHEMBL4653496

SCHEMBL4653496

O=C(CC(=O)Cc1ccc(O)cc1)Cc1ccc(O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.62
CAMK2A Q9UQM7 1/20 0.62
FNTA P49354 1/20 0.56
FNTB P49356 1/20 0.56
ESR1 P03372 3/20 0.53
ESR2 Q92731 3/20 0.53
SHBG P04278 1/20 0.53
CTBP2 P56545 1/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
LMNA P02545 1/20 0.48
KDM4E B2RXH2 1/20 0.45
F13A1 P00488 1/20 0.45
ABAT P80404 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7150590 0.90 CA2 (0.68) CA2CAMK2AFNTAFNTBESR1
SCHEMBL9638442 0.85 CA2 (0.57) CA2CAMK2AFNTAFNTBESR1
SCHEMBL5802908 0.83 CA2 (0.50) CA2CAMK2AFNTAFNTBESR1
SCHEMBL17124781 0.83 CA2 (0.60) CA2CAMK2AFNTAFNTBESR1
SCHEMBL27762917 0.81 CA2 (0.58) CA2CAMK2AFNTAFNTBESR1
SCHEMBL28165683 0.81 CA2 (0.58) CA2CAMK2AFNTAFNTBESR1
SCHEMBL27938547 0.81 CA2 (0.58) CA2CAMK2AFNTAFNTBESR1
SCHEMBL6238483 0.81 CA2 (0.58) CA2CAMK2AFNTAFNTBESR1
SCHEMBL27903659 0.81 CA2 (0.61) CA2CAMK2AFNTAFNTBESR1
SCHEMBL4029483 0.81 FNTA (0.76) CA2CAMK2AFNTAFNTBCTBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC CA2 1115/4885CAMK2A 303/4885FNTA 4286/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR CA2 2855/4885CAMK2A 4650/4885FNTA 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.